Investigators of a 3-year observational study identified independent risk factors for exacerbations related to chronic obstructive pulmonary disease (COPD) and successfully developed a novel risk ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In patients with COPD, depressive symptoms, compared ...

Using the GOLD standards for COPD staging will identify high-risk patients, improve delivery of care, and reduce health care costs. In the United States, COPD is mainly diagnosed and managed in the ...

Developing a COPD action plan helps patients improve their confidence and reduces their perceived disease burden. By creating action plans to treat chronic obstructive pulmonary disease (COPD), ...

The main outcome of the phase 3 THARROS trial will be to assess the efficacy of Breztri Aerosphere on reducing severe cardiopulmonary events in COPD patients who are at increased cardiopulmonary risk.

A new diagnostic framework for chronic obstructive pulmonary disease (COPD) that incorporates chest CT imaging and symptom assessment has redefined patient classification in large cohort studies, ...

Pulmonary assessment combines history-taking with physical examination maneuvers—inspection, palpation, percussion, and auscultation—to evaluate lung health and function. Observing breathing patterns, ...

Because PAH is progressive, ongoing risk assessment is an essential part of PAH management. Once diagnosed, the overall treatment goal for people with PAH is to achieve and maintain a low-risk status ...